Hospital Clinico Universitario de Salamanca; Servicio de Oncologia

Salamanca 37007

0 studies enrolling now · 2 studies all time

What they study most

Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN), Multiple Myeloma, Neoplasms

Studies at this site

• A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck — Stopped early
• A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers — Completed